Literature DB >> 32585073

Role of NLRP3 inflammasome in liver disease.

Abdullah Al Mamun1, Afroza Akter2, Sukria Hossain3, Tamanna Sarker4, Shoronika A Safa4, Quazi G Mustafa5, Syed A Muhammad6, Fahad Munir7.   

Abstract

Inflammasomes have become an important natural sensor of host immunity, and can protect various organs against pathogenic infections, metabolic syndromes, cellular stress and cancer metastasis. Inflammasomes are intracellular multi-protein complexes found in both parenchymal and non-parenchymal cells, stimulating the initiation of caspase-1 and interleukin (IL)-1β and IL-18 in response to cell danger signals. Inflammasomes induce cell death mechanisms. The potential role of NOD-like receptor protein 3 (NLRP3) inflammasome in alcoholic and non-alcoholic steatohepatitis, hepatitis, nanoparticle-induced liver injury and other liver diseases has recently attracted widespread attention from clinicians and researchers. In this review we summarize the role played by the NLRP3 inflammasome in molecular and pathophysiological mechanisms in the pathogenesis and progression of liver disease. This article aims to establish that targeting the NLRP3 inflammasome and other inflammasome components may make a significant therapeutic approach to the treatment of liver disease.
© 2020 Chinese Medical Association Shanghai Branch, Chinese Society of Gastroenterology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  NLRP3; caspase-1; gasdermin D; inflammasome; interleukin 1β; liver disease

Mesh:

Substances:

Year:  2020        PMID: 32585073     DOI: 10.1111/1751-2980.12918

Source DB:  PubMed          Journal:  J Dig Dis        ISSN: 1751-2972            Impact factor:   2.325


  9 in total

Review 1.  The Role of the NLRP3 Inflammasome in HCC Carcinogenesis and Treatment: Harnessing Innate Immunity.

Authors:  Stavros P Papadakos; Nikolaos Dedes; Elias Kouroumalis; Stamatios Theocharis
Journal:  Cancers (Basel)       Date:  2022-06-27       Impact factor: 6.575

Review 2.  Role of Sodium-Glucose Co-Transporter 2 Inhibitors in the Regulation of Inflammatory Processes in Animal Models.

Authors:  Sandra Feijóo-Bandín; Alana Aragón-Herrera; Manuel Otero-Santiago; Laura Anido-Varela; Sandra Moraña-Fernández; Estefanía Tarazón; Esther Roselló-Lletí; Manuel Portolés; Oreste Gualillo; José Ramón González-Juanatey; Francisca Lago
Journal:  Int J Mol Sci       Date:  2022-05-18       Impact factor: 6.208

Review 3.  Mitochondria and the NLRP3 Inflammasome in Alcoholic and Nonalcoholic Steatohepatitis.

Authors:  Sandra Torres; Paula Segalés; Carmen García-Ruiz; José C Fernández-Checa
Journal:  Cells       Date:  2022-04-27       Impact factor: 7.666

Review 4.  Regulatory Roles of Caspase-11 Non-Canonical Inflammasome in Inflammatory Liver Diseases.

Authors:  Young-Su Yi
Journal:  Int J Mol Sci       Date:  2022-04-30       Impact factor: 6.208

Review 5.  NLRP3 Inflammasome and Pyroptosis in Liver Pathophysiology: The Emerging Relevance of Nrf2 Inducers.

Authors:  Laura Hurtado-Navarro; Diego Angosto-Bazarra; Pablo Pelegrín; Alberto Baroja-Mazo; Santiago Cuevas
Journal:  Antioxidants (Basel)       Date:  2022-04-28

6.  TGF-β activates NLRP3 inflammasome by an autocrine production of TGF-β in LX-2 human hepatic stellate cells.

Authors:  Hwansu Kang; Eunhui Seo; Yoon Sin Oh; Hee-Sook Jun
Journal:  Mol Cell Biochem       Date:  2022-02-09       Impact factor: 3.396

Review 7.  The Role of Endoplasmic Reticulum Stress and NLRP3 Inflammasome in Liver Disorders.

Authors:  Xueqin Lu; Haitao Huang; Xiaodi Fu; Chaoran Chen; Huiyang Liu; Honggang Wang; Dongdong Wu
Journal:  Int J Mol Sci       Date:  2022-03-24       Impact factor: 5.923

8.  Adipose-Derived Mesenchymal Stromal/Stem Cell Line Prevents Hepatic Ischemia/Reperfusion Injury in Rats by Inhibiting Inflammasome Activation.

Authors:  Kaili Chen; Hideaki Obara; Yumiko Matsubara; Kazumasa Fukuda; Hiroshi Yagi; Yukako Ono-Uruga; Kentaro Matsubara; Yuko Kitagawa
Journal:  Cell Transplant       Date:  2022 Jan-Dec       Impact factor: 4.139

Review 9.  Inflammation and Inflammasomes: Pros and Cons in Tumorigenesis.

Authors:  Liliana R Balahura; Aida Selaru; Sorina Dinescu; Marieta Costache
Journal:  J Immunol Res       Date:  2020-09-19       Impact factor: 4.818

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.